Financial Year |
March 31 2023 |
Monetary Funds |
623,994,450.35 |
Held-for-trading Financial Assets |
200,192,805.53 |
Notes Receivable |
24,540,329.23 |
Accounts Receivable |
227,297,565.02 |
Advances to Suppliers |
37,764,068.21 |
Other Receivables |
7,116,651.44 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
6,915.24 |
Dividend Receivable |
-- |
Inventories |
246,025,823.40 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
2,056,299.27 |
Total Current Assets |
1,378,268,397.37 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
4,350,195.54 |
Long-term Equity Investment |
1,302,633.75 |
Investment Properties |
-- |
Fixed Assetes |
281,834,240.89 |
Under-construction Projects |
31,058,375.81 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
85,645,490.56 |
R&D expenses |
-- |
Goodwill |
-- |
Long-Term Deferred and Prepaid Expenses |
-- |
Deferred Income Tax Assets |
41,014,338.18 |
Other Non-Current Assets |
74,555,626.64 |
Sub-Total of Non-Current Assets |
519,760,901.37 |
Total Assets |
1,898,029,298.74 |
Short-Term Loans |
-- |
Trading Financial liabilities |
-- |
Notes Payable |
27,115,418.11 |
Accounts Payable |
90,888,456.38 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
4,658,992.29 |
Taxes Payable |
1,418,859.85 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
1,729,274.55 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
-- |
Other Current Liabilities |
18,696,685.63 |
Sub-Total of Current Liabilities |
194,798,622.46 |
Long-term Loans |
-- |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
-- |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
2,792,405.70 |
Total Liabilities |
197,591,028.16 |
Paid-In Capital(Or Share Stock) |
479,993,598.00 |
Capital Surplus |
2,280,316,735.99 |
Surplus Reserve |
58,537,549.55 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
-1,115,921,618.28 |
Minority Stockholder's Interest |
-2,487,994.68 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,702,926,265.26 |
Owner's Equity(Stockholder's Equity) |
1,700,438,270.58 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
1,898,029,298.74 |